ACTIVE RECALL — CLASS IIActive recallD-0419-2025/FDA enforcement
L'oreal USA·Cosmetics·Mar 5, 2025

La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl…

What you need to know

Class II
  • What happened

    CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the…

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A known human carcinogen that can be introduced through contaminated ingredients or manufacturing processes.

  • Action required

    Stop applying or using the product. Check the UPC and lot codes below, then return it to the retailer or contact the manufacturer about a refund or replacement.

Active recall · classified by the FDANationwide (US)More cosmetics

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA COSMETICS

Brand nameL'oreal USA
Recalling firmL'oreal USAClark, NJ, United States
UPC / barcodes
3 606000 50880 48 83140 50075 9
Lot / date codes
  • a) Lot #s, Expiration dates: MYX30W 03/2025 MYX43W 04/2025 MYX41W 04/2025 MYX42W 04/2025 MYX40W 04/2025 MYX51W 05/2025 MYX50W 05/2025 MYX60W 05/2025 MYX71W 06/2025 MYX90W 08/2025 MYX91W 09/2025 MYX92W 08/2025 MYXO0W 09/2025 MYX93W 09/2025 MYXD1W 11/2025 MYXD2W 11/2025 MYXDOW 09/2025 MYXD4W 11/2025 MYXD3W 11/2025 MYY22W 02/2026 MYY21W 02/2026 MYY20W 02/2026 MYY41W 04/2026 MYY40W 04/2026 MYY42W 04/2026 MYY43W 04/2026 MYY52W 05/2026 MYY51W 05/2026 MYY50W 05/2026 MYY60W 06/2026 b) Lot #s, Expiration dates MYX31W 3/2025 MYX32W 3/2025 MYX33W 3/2025 MYX34W 3/2025 MYX35W 3/2025 MYX40W 3/2025 MYX41W 4/2025 MYX42W 4/2025 MYX44W 4/2025 MYX45W 4/2025 MYX47W 4/2025 MYX48W 4/2025 MYX49W 4/2025 MYX50W 5/2025 MYX51W 5/2025 MYX52W 5/2025 MYX70W 6/2025 MYX71W 6/2025 MYX72W 7/2025 MYX73W 7/2025 MYX74W 7/2025 MYX75W 7/2025 MYX77W 7/2025 MYX78W 7/2025 MYX80W 8/2025 MYX81W 7/2025 MYX82W 8/2025 MYX83W 8/2025 MYX84W 7/2025 MYXO0W 9/2025 MYXO1W 8/2025 MYXO3W 8/2025 MYXO4W 9/2025 MYXO5W 9/2025 MYXO7W 9/2025 MYXO8W 8/2025 MYXO9W 9/2025 MYXD0W 11/2025 MYXD1W 12/2025 MYXD2W 11/2025 MYXD3W 11/2025 MYXD4W 11/2025 MYXD5W 11/2025 MYXD6W 12/2025 MYY22W 02/2026 MYY23W 02/2026 MYY30W 02/2026 MYY31W 03/2026 MYY32W 03/2026 MYY40W 03/2026 MYY41W 04/2026 MYY42W 04/2026 MYY43W 04/2026 MYY51W 04/2026 MYY60W 06/2026 MYY61W 06/2026 MYY62W 06/2026 MYY63W 06/2026 MYY64W 06/2026 MYY65W 06/2026 MYY66W 06/2026
Distribution area
Nationwide

Nationwide in the USA

United States

Quantity affectedNot provided by the FDA.
Recall initiationFDA report date: May 21, 2025
FDA recall numberD-0419-2025

Beyond the headline

The recall, in context

L'oreal USA initiated this cosmetics recall on March 5, 2025. The FDA enforcement report states: CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots. The FDA report lists distribution as: Nationwide in the USA.

The FDA enforcement report describes the reason as: CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.

La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl… was made or distributed by L'oreal USA in Clark, NJ, United States. This page reflects FDA report D-0419-2025, dated May 21, 2025.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a known human carcinogen that can be introduced through contaminated ingredients or manufacturing processes.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Set the product aside and do not apply it.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Benzene contamination

Possible health effects

Benzene is a known human carcinogen. Long-term exposure is associated with blood disorders and cancer. A recall is a precautionary step to reduce exposure.

When symptoms may appear

Health effects are generally associated with repeated or long-term exposure rather than a single incubation period.

Higher-risk groups

People who use the affected product frequently, pregnant people, children and people with existing blood disorders should be especially cautious.

What to do now

  1. 1Stop using the affected cosmetic or personal-care product immediately.
  2. 2Keep the package and contact the retailer or manufacturer about a refund or replacement; do not use it as a substitute.
  3. 3If you have concerns about exposure or symptoms, speak with a healthcare professional.

Benzene is a known human carcinogen; this information is not a personal exposure assessment.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl… recall?

L'oreal USA recalled La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl… in an FDA Class II enforcement action reported as D-0419-2025. CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the…

What should I do if I bought this product?

Stop applying or using the product. Check the UPC and lot codes below, then return it to the retailer or contact the manufacturer about a refund or replacement. Stop using the affected cosmetic or personal-care product immediately. Keep the package and contact the retailer or manufacturer about a refund or replacement; do not use it as a substitute. If you have concerns about exposure or symptoms, speak with a healthcare professional.

Is the L'oreal USA recall still active?

Yes. As of the latest FDA enforcement report, this recall is listed as ongoing. Check the official source record for the most current status before making a decision.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record D-0419-2025. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by L'oreal USA

View brand

Related alerts

Recent Benzene recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.